NCT01807338View on ClinicalTrials.gov

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Parkinson's Disease
Trial Locations (1)

221 85

Department of Neurology, Skåne University Hospital, Lund

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

TFS Trial Form Support

INDUSTRY

lead

Newron Sweden AB

INDUSTRY

NCT01807338 - A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter